207 related articles for article (PubMed ID: 18388118)
1. Successful re-challenge with darbepoetin in a patient with rHu-EPO-induced pure red cell aplasia refractory to immunosuppressive drugs.
Viron B; Dupuy CA; Kolta A; Casadevall N
Nephrol Dial Transplant; 2008 Jul; 23(7):2416-8. PubMed ID: 18388118
[No Abstract] [Full Text] [Related]
2. Successful re-introduction of recombinant human erythropoietin following antibody induced pure red cell aplasia.
Summers SA; Matijevic A; Almond MK
Nephrol Dial Transplant; 2004 Aug; 19(8):2137-9. PubMed ID: 15252175
[No Abstract] [Full Text] [Related]
3. Antibody-mediated acquired pure red cell aplasia (PRCA) after treatment with darbepoetin.
Howman R; Kulkarni H
Nephrol Dial Transplant; 2007 May; 22(5):1462-4. PubMed ID: 17314208
[No Abstract] [Full Text] [Related]
4. Antiepoetin antibody-related pure red cell aplasia: successful remission with cessation of recombinant erythropoietin alone.
Katagiri D; Shibata M; Katsuki T; Masumoto S; Katsuma A; Minami E; Hoshino T; Inoue T; Tada M; Hinoshita F
Clin Exp Nephrol; 2010 Oct; 14(5):501-5. PubMed ID: 20652821
[TBL] [Abstract][Full Text] [Related]
5. Pure red cell aplasia secondary to epoetin alpha responding to Darbepoetin alpha in a patient on peritoneal dialysis.
Asari A; Gokal R
J Am Soc Nephrol; 2004 Aug; 15(8):2204-7. PubMed ID: 15284306
[TBL] [Abstract][Full Text] [Related]
6. Antibody-mediated pure red cell aplasia in a dialysis patient receiving darbepoetin alfa as the sole erythropoietic agent.
Jacob A; Sandhu K; Nicholas J; Jones H; Odum J; Rylance P; Carmichael P; Jackson M; Handa S; Macwhannell A; Basu S; Wahid F; Casadevall N; Mufti G; Macdougall I
Nephrol Dial Transplant; 2006 Oct; 21(10):2963-5. PubMed ID: 16861239
[No Abstract] [Full Text] [Related]
7. Improvement in erythropoieis-stimulating agent-induced pure red-cell aplasia by introduction of darbepoetin-α when the anti-erythropoietin antibody titer declines spontaneously.
Lee H; Yang J; Kim H; Kwon JW; Oh KH; Joo KW; Kim YS; Ahn C; Han JS; Kim S
J Korean Med Sci; 2010 Nov; 25(11):1676-9. PubMed ID: 21060762
[TBL] [Abstract][Full Text] [Related]
8. Epoetin-induced autoimmune pure red cell aplasia.
Casadevall N
Hematol J; 2004; 5 Suppl 3():S104-9. PubMed ID: 15190289
[No Abstract] [Full Text] [Related]
9. Resolution of epoetin-induced pure red cell aplasia 2 years later, successful re-challenge with continuous erythropoiesis receptor stimulator.
Lim SK; Bee PC; Keng TC; Chong YB
Clin Nephrol; 2013 Sep; 80(3):227-30. PubMed ID: 23298519
[TBL] [Abstract][Full Text] [Related]
10. Antibody-mediated pure red-cell aplasia (PRCA): the Spanish experience.
Carracedo J; Madueño JA; Ramirez R; Martin-Malo A; de Francisco AL; Aljama P;
J Nephrol; 2005; 18(4):382-7. PubMed ID: 16245241
[TBL] [Abstract][Full Text] [Related]
11. Anti-epoetin-antibody-induced anemia in a child with chronic renal failure.
Jöbsis JJ; Fijnvandraat K; Stapel SO; Bouts AH
Pediatr Nephrol; 2010 May; 25(5):993-4. PubMed ID: 20165889
[No Abstract] [Full Text] [Related]
12. Biosimilar epoetins.
Macdougall IC
Nephrol Dial Transplant; 2009 May; 24(5):1698-9; author reply 1699-700. PubMed ID: 19366858
[No Abstract] [Full Text] [Related]
13. Pure red cell aplasia caused by antibody to erythropoietin successfully treated by cyclosporine administration.
Shinohara K
Am J Hematol; 2007 Mar; 82(3):247-8. PubMed ID: 16947314
[No Abstract] [Full Text] [Related]
14. Erythropoietin-induced, antibody-mediated pure red cell aplasia.
Rossert J;
Eur J Clin Invest; 2005 Dec; 35 Suppl 3():95-9. PubMed ID: 16281965
[TBL] [Abstract][Full Text] [Related]
15. Anti-erythropoietin antibodies followed by endogenous erythropoietin production in a dialysis patient.
Mattison P; Upadhyay K; Wilcox JE; Moudgil A; Silverstein DM
Pediatr Nephrol; 2010 May; 25(5):971-6. PubMed ID: 20091055
[TBL] [Abstract][Full Text] [Related]
16. Pure red cell aplasia induced by anti-erythropoietin antibodies, well-controlled with tacrolimus.
Hashimoto K; Harada M; Kamijo Y
Int J Hematol; 2016 Oct; 104(4):502-5. PubMed ID: 27338269
[TBL] [Abstract][Full Text] [Related]
17. Response to cyclosporine A in a patient with pure red cell aplasia due to antierythropoietin-alpha antibodies.
Fraer M; Campbell A; Sawaya BP
Semin Dial; 2006; 19(3):251-4. PubMed ID: 16689978
[TBL] [Abstract][Full Text] [Related]
18. Anti-erythropoietin and anti-thrombopoietin antibodies induced after administration of recombinant human erythropoietin.
Shin SK; Pack SP; Oh JG; Kang NK; Chang MH; Chung YH; Kim SJ; Lee JW; Heo TH
Int Immunopharmacol; 2011 Dec; 11(12):2237-41. PubMed ID: 22051973
[TBL] [Abstract][Full Text] [Related]
19. Treatment of erythropoietin-induced pure red cell aplasia: a retrospective study.
Verhelst D; Rossert J; Casadevall N; Krüger A; Eckardt KU; Macdougall IC
Lancet; 2004 May; 363(9423):1768-71. PubMed ID: 15172775
[TBL] [Abstract][Full Text] [Related]
20. Antibody-mediated pure red cell aplasia due to epoetin alfa during antiviral therapy of chronic hepatitis C.
Stravitz RT; Chung H; Sterling RK; Luketic VA; Sanyal AJ; Price AS; Purrington A; Shiffman ML
Am J Gastroenterol; 2005 Jun; 100(6):1415-9. PubMed ID: 15929778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
